Published: 2018-04-23

Drug utilization pattern in pregnancy at a tertiary care hospital in Puducherry: a cross sectional observational study

Nitya Selvaraj, Anugraha Sekar, Ramya Gandhi, Nalinidevi Jayabalan, Suganya Ganesan, Meher Ali Raja Mohammad


Background: Drug utilization pattern in pregnancy population provide insights regarding drug profile and interventional measures and also minimizes the inherent risk occurring due to unethical prescription.

Methods: It was a prospective cross sectional study where prescription slips were collected. Further drugs were categorized according to the classification defined by US Food and drug Administration for pregnancy. Using Pre validated questionnaire the pregnant women were interviewed and parameters regarding knowledge about antenatal visit and contraception, self-medication practices were noted.

Results: Among the total 365 participants, 81.4% had finish their high schooling and were in reproductive age group of 22-25. Study revealed predominant usage category- A drugs in I (95.5%), II (97.8%), III (96.4%) trimester. None of them received Category D or X drugs. Almost 100% and 98.6% in III and II trimester respectively received iron. Other drugs prescribed were calcium, anti-emetics, anti-ulcer, NSAIDS and antimicrobial. The awareness about Intra Uterine Contraceptive Devices and Oral Contraceptive Pills were 48.2% and 31.5% respectively. Unfortunately only 4.9% felt that drug use could be dangerous to foetus. 58.9% were aware about antenatal examination during pregnancy.

Conclusions: Evaluation of drug utilization pattern periodically will minimize incidence of risk to foetus and mother during pregnancy.


Drug utilization pattern, Pregnancy

Full Text:



Deborah E, Mc Carter, Spaulding MS. Medications in pregnancy and lactation. Amer J Maternal Child Nursing. 2005;30:10-7.

Uchenna IE, Adego EE, Azuka CO, Ehijie FE. Assessment of Prescription profile of pregnant women visiting antenatal clinics. Pharmacy Practice. 2007;5(3):135-9.

Sachdeva P, Patel BG. Drug use in pregnancy; a point to ponder Indian J Pharm Sci. 2009;71:1-7.

Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet 2011;157:175-82.

Blot I, Papiernik E, Kaltwasser JP, Werner E, Tchernia G, Influence of routine administration of folic acid and iron during pregnancy. Gynecol Obstet Invest. 1981;12:294-304.

Sharma R. Kapoor B, Verma U. Drug Utilization Pattern during pregnancy in North India. J Med Sci. 2006;60:277-87.

Sorensan MK, Philips BB, Mutnick AH. Drug use in specific patient population: pediatric, pregnant, geriatric in: Shargel L. Mutnick A, editors. Comprehensive Pharmacy Review, 5th Ed. Philadelphia, Lippincott William Wilkins; 2008:673-682.

Kraemer K. Placental transfer of drugs. Neonatal Network. 1997;16:65-7.

Kallen BA. Methodological issues in the epidemiological study of the teratogenicity of drugs. Congenital Anomalies. 2005;45:44-51.

Koren G, Pastuszak A, Ito S. Drugs in pregnancy. New England Journal of Medicine. 1998;2(7):547-54.

Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use During pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register. Clinical Epidemiology. 2011;3:43-50.

Das B, Sarkar C, Datta A, Bohra S. A study of drug use during pregnancy in a teaching hospital in western Nepal. Pharmacoepidiology and drug safety. 2003;12:221-5.

Kureshee NI, Dhande PP. Awareness of Mothers and Doctors about Drug Utilization Pattern for Illnesses Encountered during Pregnancy. JCDR. 2013;7:2470-4.

FDA class: Drugs in Pregnancy and Lactation, 5th Ed. Wilkins and Wilkin: Baltimore; 1998.

Rathnakar UP, Singh N. Drug utilization patterns drug antenatal period, Journal of Pharmacy Research. 2011;4(10):3359-561.

Joshi H, Patel S, Patel K, Patel V. Drug use Pattern during pregnancy: A Prospective study at Tertiary Care Teaching Hospital. NHL Journal of Medical Science. 2012;1(1):14-7.

Filcadu M, Kebebe D, Amelo W, Gashe F. Drug Utilization Pattern and Potential Teratogenicity Risk among Pregnant Women Visiting Antenatal clinic. The case of primary hospital. NHL Journal of Medical Science. 2012;1(1):27-33.

Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription hospital drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398-407.

World Health Organization (WHO), Iron deficiency anaemia; assessment, prevention and control: a guide to programme managers, WHO /NHD/ 01.3, 2001. Available at: http: // publications/ en / ida_assessment_prevention_ control. Pdf.

Von Dadelszen P, Firoz T, Donnay F, Gordan R, Hofmeyr GJ, Lalani S, et al. Preeclampsia in low and middle-income countries- health services lessons learnt from the PRE-EMPT (PRE-eclampsia- Eclampsia Monitoring, Prevention and Treatment) project. J Obstet Gynaecol Can. 2012;34:917-26.

Drhova L. Knowledge, attitudes, and behaviour of the population of the Czech Republic to self-medication- II. Knowledge of and information about drugs. CeskaSlov Farm. 2005;54:168-72.

Mohmmed F, Musa A, Amano A. Prevalence and determinants of unintended Pregnancy among pregnant woman attending ANC at Gelemso General Hospital, Oromiya Region, East Ethiopia: A facility based cross-sectional study. BMC Women’s Health 2016;16:56.

Tappis H, Kazi A, Hameed W, Dahar Z, Ali A, Agha S. The role of quality health services and discussion about birth spacing in postpartum contraceptive use in Sindh, Pakistan: a multilevel analysis. PloS one. 2015 Oct 20;10(10):e0139628.